Population Pharmacokinetics and Exposure‐Response Model‐Based Bayesian Extrapolation of FVC‐Based Efficacy Endpoints From Adults to Pediatric Patients Receiving Nintedanib

MIDD

Regulatory interactions

Specific populations

Pharmacometrics

Respiratory

Program strategies and efficiencies

Methodology

CPT Pharmacometrics Syst Pharmacol. 2025 Dec 9. Online ahead of print.

Hartman S, Chan Kwong A, Ribbing J, Gahlemann M, Korell J